Canada's Second Blood Clot Case After An AstraZeneca Dose Has Been Reported In Alberta

Alberta is reporting Canada's second instance of a blood clot case in someone who received a dose of an AstraZeneca COVID-19 vaccine.

The province's Chief Medical Officer of Health Dr. Deena Hinshaw said the patient, who is a male in his 60s, is now recovering after receiving treatment for Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT). 

Editor's Choice: 8 Ontario Police Forces Say They Won't Be Doing Random Stops With The New COVID-19 Rules

Hinshaw said in a statement that she continues "to recommend AstraZeneca for anyone who is 55 and older, and to recommend that all Albertans get vaccinated as soon as they are able. It is the best way to protect your health and the health of those around you." 

She also maintained that this reaction is extremely rare and that Albertans who are 55 and older are "at least 1,500 times more likely to be hospitalized from COVID-19 than experiencing VITT after getting AstraZeneca."

This is Canada's second instance in over 700,000 doses given after another case was reported. That person was also treated and is recovering. 

Health Canada has a robust website with all the latest information on the vaccines and can answer any questions you may have. Click here for more information.